By Josh White
Date: Friday 15 Dec 2023
LONDON (ShareCast) - (Sharecast News) - Aptamer Group reported solid progress on both the technical and commercial fronts on Friday as it held its annual general meeting.
The AIM-traded firm said that since its recapitalisation in August, it had undergone a cost reduction initiative, streamlining production processes to boost capacity, and decreased material requirements from customers.
It also continued to expand and convert its commercial pipeline, with a recent partnership involving a genetic medicines company to advance Optimer development, facilitating targeted delivery of new medicines.
At 1121 GMT, shares in Aptamer Group were down 2.5% at 1.17p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 0.73p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 25.50 |
52 Week Low | 0.50 |
Volume | 0 |
Shares Issued | 467.34m |
Market Cap | £3.39m |
Beta | 0.16 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
You are here: research